Q3 2016 Holdings
Filed 2016-11-14 | 48 holdings | $93.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $38.8M | 419,712 | 41.4% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $25.2M | 792,499 | 26.9% |
| Akebia Therapeutics Inc(AKBA) | Common | 00972D105 | $8.5M | 944,579 | 9.1% |
| Agios Pharmaceuticals Inc(AGIO) | Common | 00847X104 | $7.9M | 150,000 | 8.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $6.1M | 1,379,402 | 6.5% |
| Corvus Pharmaceuticals Inc(CRVS) | Common | 221015100 | $4.4M | 268,369 | 4.7% |
| Cellectis(CLLS) | Sponsored ADR | 15117K103 | $1.4M | 58,671 | 1.5% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $909.0K | 45,203 | 1.0% |
| Sarepta Theraputics Inc(SRPT) | Common | 803607100 | $84.1K | 1,369,909 | 0.1% |
| Lion Biotechnologies Inc | Common | 53619R102 | $35.0K | 4,257,347 | 0.0% |
| Tesaro Inc | Common | 881569107 | $27.8K | 277,703 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $27.3K | 3,689,857 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $27.3K | 805,926 | 0.0% |
| Agenus Inc(AGENEUR) | Common | 00847G705 | $26.7K | 3,715,938 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | Common | 64125C109 | $24.8K | 490,582 | 0.0% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $23.9K | 7,344,177 | 0.0% |
| Bristol Myers Squibb Co.(BMY) | Common | 110122108 | $21.6K | 399,875 | 0.0% |
| Global Blood Therapeutics | Common | 37890U108 | $20.0K | 869,263 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | Common | 00771V108 | $18.9K | 500,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $17.7K | 133,600 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $13.8K | 827,693 | 0.0% |
| Neuroderm LTD | Common | M74231107 | $12.7K | 686,303 | 0.0% |
| Teligent Inc | Common | 87960W104 | $12.4K | 1,637,819 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | Common | 83587F202 | $11.9K | 1,531,273 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $9.8K | 1,488,487 | 0.0% |
| Cascadian Therapeutics Inc | Common | 14740B101 | $9.2K | 5,611,323 | 0.0% |
| Seattle Genetics Inc | Common | 812578102 | $7.6K | 141,500 | 0.0% |
| Veracyte Inc(VCYT) | Common | 92337F107 | $7.0K | 918,556 | 0.0% |
| Sarepta Theraputics Inc(SRPT)Call | Common | 803607100 | $6.0K | 190,000 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $5.3K | 3,575,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $4.7K | 316,020 | 0.0% |
| Fortress Biotech Inc | Common | 34960Q109 | $4.0K | 1,356,636 | 0.0% |
| Proteostasis Therapeutics Inc | Common | 74373B109 | $2.8K | 179,565 | 0.0% |
| Innocoll Holdings PLC | Shares | G4783X105 | $2.7K | 468,148 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $2.1K | $7,000,000 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $1.9K | 268,119 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $1.9K | 450,872 | 0.0% |
| Versartis Inc | Common | 92529L102 | $1.2K | 95,742 | 0.0% |
| Oncomed Pharmaceuticals Inc | Common | 68234X102 | $972 | 85,000 | 0.0% |
| Agenus Inc(AGENEUR)Call | Common | 00847G705 | $800 | 1,000,000 | 0.0% |
| Cempra Inc | Common | 15130J109 | $726 | 30,000 | 0.0% |
| Vericel Corp(VCEL) | Common | 92346J108 | $604 | 215,744 | 0.0% |
| Nantkwest Inc | Common | 63016Q102 | $563 | 72,412 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | Common | 253031108 | $271 | 46,082 | 0.0% |
| Oncobiologics Inc - Warrant B | Warrant | 68235M121 | $233 | 233,333 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $112 | 233,333 | 0.0% |
| Immunomedics Inc(IMMU)Call | Common | 452907108 | $53 | 300,800 | 0.0% |
| Sarepta Theraputics Inc(SRPT)Put | Common | 803607100 | $2 | 75,600 | 0.0% |